ArticleScientific reports2026
A novel prognostic nomogram for elderly renal cell carcinoma patients with lung metastases.
Article in Scientific reports, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
4 authors.
Funding
Abstract
Research on the prognosis of elderly renal cell carcinoma (RCC) patients with lung metastases (LM) remains limited. This study aimed to develop and validate a prognostic model for this population and to identify key determinants of overall survival (OS). We extracted data on RCC patients aged ≥ 65 years diagnosed with LM between 2010 and 2019 from the SEER database. Independent risk factors for OS, identified through univariate and multivariate Cox regression, were incorporated into a prognostic nomogram. The model's performance was assessed using the C-index, ROC curves, calibration plots, and decision curve analysis (DCA). The XGBoost algorithm was employed to rank feature importance for OS at different time points. Subsequent propensity score matching (PSM) was used to balance baseline characteristics, enabling a comparison of OS between surgical and non-surgical groups via Kaplan-Meier analysis. Among 1,835 patients (2010-2017), a 7:3 split created training and internal validation cohorts; an additional 548 patients (2018-2019) served as an external validation cohort. The final nomogram integrated 11 variables: age, marital status, histologic type, grade, T stage, N stage, surgery, chemotherapy, and metastases to bone, brain, and liver. Internal and external validation confirmed the model's robust predictive accuracy and clinical utility. XGBoost analysis consistently identified surgery as the most critical prognostic factor. After PSM, the surgical group demonstrated significantly superior OS across all cohorts. In conclusion, we developed a practical nomogram for predicting OS in elderly RCC patients with LM. Our findings strongly suggest that surgical intervention is independently associated with markedly improved survival in this patient population.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.